ArticleQuantitative imaging in medicine and surgery2026
Validation of voxel-based computed tomography liver fat quantification for assessing incident type 2 diabetes risk in a health check-up population.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Conventional computed tomography (CT)-based liver fat assessment relies mainly on mean attenuation or liver-to-spleen ratios, whereas a novel voxel-based approach enables whole-liver, voxel-level quantification of hepatic fat. However, its value for predicting incident type 2 diabetes (T2D) remains unclear. Therefore, this study aimed to validate whether voxel-based liver fat quantification derived from routine CT can be used to assess the risk of incident T2D in a health check-up population. Methods: In this retrospective cohort study, individuals who underwent routine noncontrast abdominal CT examinations between January 2013 and December 2023 and were free of diabetes at baseline were included. Liver fat was quantified via an automated voxel-based method incorporating spleen-referenced attenuation criteria on the basis of whole-liver segmentation. The average liver fat fraction was defined as the proportion of liver voxels classified as fat. Incident T2D was identified through longitudinal review of outpatient, inpatient, and health check-up records. Associations between liver fat and incident T2D were evaluated via Cox proportional hazards models adjusted for demographic, anthropometric, and metabolic covariates. Restricted cubic spline (RCS) analysis was used to explore dose-response relationships. Predictive performance was assessed via time-dependent receiver operating characteristic (ROC) analysis at 3 and 5 years, calibration plots, and decision curve analysis (DCA). Incremental predictive value was evaluated by comparing liver fat-based models with hemoglobin A1c (HbA1c)-based and clinical models. Results: Among 356 participants [median age, 57 years, interquartile range (IQR), 53-63 years; 56.5% male], 32 individuals (9.0%) developed incident T2D during a median follow-up of 4.5 years. A higher average liver fat fraction was significantly associated with an increased risk of incident T2D after multivariable adjustment [hazard ratio (HR) per standard deviation (SD), 1.65; 95% confidence interval (CI): 1.05-2.60, P=0.031]. RCS analysis demonstrated a monotonic increase in diabetes risk with increasing liver fat fraction. The liver fat fraction showed moderate discrimination for incident T2D, with time-dependent area under the curve (tAUC) values of 0.71 (95% CI: 0.59-0.84) at 3 years and 0.72 (95% CI: 0.60-0.82) at 5 years. Compared with clinical variables or HbA1c alone, the addition of liver fat improved predictive performance for incident T2D, increasing the C-index from 0.574 (0.453-0.680) to 0.740 (95% CI: 0.663-0.803). Conclusions: Voxel-based CT quantification of liver fat is independently associated with incident T2D and provides incremental value for diabetes risk assessment in a health check-up population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.